Mibefradil and an effective formulary system.
Vermeulen
L C
LC
Dunham
D B
DB
D001562:Benzimidazoles / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D017277:Drug Approval; D005569:Formularies as Topic; D006801:Humans; D020748:Mibefradil; D013764:Tetrahydronaphthalenes / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil